Alaswad Zina, Attallah Nayera E, Aboalazm Basma, Elmeslhy Eman S, Mekawy Asmaa S, Afify Fatma A, Mahrous Hesham K, Abdalla Ashrakat, Rahmoon Mai A, Mohamed Ahmed A, Shata Ahmed H, Mansour Rana H, Aboul-Ela Fareed, Elhadidy Mohamed, Javierre Biola M, El-Khamisy Sherif F, Elserafy Menattallah
Center for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt; University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
Center for Genomics, Helmy Institute for Medical Sciences, Zewail City of Science and Technology, Giza, Egypt; Department of Pharmaceutical Biology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Egypt.
J Genet Eng Biotechnol. 2024 Dec;22(4):100427. doi: 10.1016/j.jgeb.2024.100427. Epub 2024 Oct 19.
The utilization of human cDNA libraries in yeast genetic screens is an approach that has been used to identify novel gene functions and/or genetic and physical interaction partners through forward genetics using yeast two-hybrid (Y2H) and classical cDNA library screens. Here, we summarize several challenges that have been observed during the implementation of human cDNA library screens in Saccharomyces cerevisiae (budding yeast). Upon the utilization of DNA repair deficient-yeast strains to identify novel genes that rescue the toxic effect of DNA-damage inducing drugs, we have observed a wide range of transcripts that could rescue the strains. However, after several rounds of screening, most of these hits turned out to be false positives, most likely due to spontaneous mutations in the yeast strains that arise as a rescue mechanism due to exposure to toxic DNA damage inducing-drugs. The observed transcripts included mitochondrial hits, non-coding RNAs, truncated cDNAs, and transcription products that resulted from the internal priming of genomic regions. We have also noticed that most cDNA transcripts are not fused with the GAL4 activation domain (GAL4AD), rendering them unsuitable for Y2H screening. Consequently, we utilized Sanger sequencing to screen 282 transcripts obtained from either four different yeast screens or through direct fishing from a human kidney cDNA library. The aim was to gain insights into the different transcription products and to highlight the challenges of cDNA screening approaches in the presence of a significant number of undesired transcription products. In summary, this study describes the challenges encountering human cDNA library screening in yeast as a valuable technique that led to the identification of important molecular mechanisms. The results open research venues to further optimize the process and increase its efficiency.
在酵母遗传筛选中利用人类cDNA文库是一种通过酵母双杂交(Y2H)正向遗传学和经典cDNA文库筛选来鉴定新基因功能及/或遗传和物理相互作用伙伴的方法。在此,我们总结了在酿酒酵母(芽殖酵母)中进行人类cDNA文库筛选时观察到的几个挑战。在利用DNA修复缺陷型酵母菌株来鉴定可挽救DNA损伤诱导药物毒性作用的新基因时,我们观察到大量可挽救这些菌株的转录本。然而,经过几轮筛选后,这些命中结果大多被证明是假阳性,很可能是由于酵母菌株中因接触有毒的DNA损伤诱导药物而作为一种挽救机制出现的自发突变。观察到的转录本包括线粒体命中结果、非编码RNA、截短的cDNA以及由基因组区域内部引发产生的转录产物。我们还注意到,大多数cDNA转录本未与GAL4激活结构域(GAL4AD)融合,这使得它们不适用于Y2H筛选。因此,我们利用桑格测序法筛选了从四个不同酵母筛选或通过从人类肾脏cDNA文库直接钓取获得的282个转录本。目的是深入了解不同的转录产物,并突出在存在大量不需要的转录产物的情况下cDNA筛选方法所面临的挑战。总之,本研究描述了在酵母中进行人类cDNA文库筛选时遇到的挑战,这是一种有价值的技术,已导致重要分子机制的鉴定。这些结果为进一步优化该过程并提高其效率开辟了研究途径。